Post-approval studies (Phase 4)Study completedNCT02019784
What this trial is testing
Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy
Who this might be right for
Liver CirrhosisHepatoencephalopathy, Early Fatal Progressive
King's College Hospital NHS Trust 38